1-7 of 7
Jeffrey S. Wasser
Close
Sort by
Journal Articles

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Karynsa Cetin, Leah J McGrath, PhD, Robert Overman, PhD, Diane Reams, Pharm.D., MPH, Anjali Sharma, MD, M. Alan Brookhart, PhD, Ivy Altomare, MD, Jeffrey S. Wasser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 497.
https://doi.org/10.1182/blood-2018-99-117252
Published: 2018
Journal Articles

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data

Shuling Li, PhD, Julia T Molony, MS, Karynsa Cetin, MPH, Jeffrey S Wasser, MD, Ivy Altomare, MD
Journal: Blood
Blood (2015) 126 (23): 38.
https://doi.org/10.1182/blood.V126.23.38.38
Published: 2015
Journal Articles

Cost of Bleeding-Related Episodes (BREs) in Adult Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States

Junji Lin, PhD, Xinke Zhang, MS, Xiaoyan Li, PhD, Ivy Altomare, MD, Jeffrey S Wasser, MD, Karynsa Cetin, MPH
Journal: Blood
Blood (2015) 126 (23): 3274.
https://doi.org/10.1182/blood.V126.23.3274.3274
Published: 2015
Journal Articles

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

Yueming Chang, MD PhD, Jeffrey S Wasser, MD, Adam Boruchov, MD, Bruce J Mayer, PhD, Kazuya Machida, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4128.
https://doi.org/10.1182/blood.V126.23.4128.4128
Published: 2015
Journal Articles

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, Roger M Lyons, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun
Journal: Blood
Blood (2010) 116 (21): 68.
https://doi.org/10.1182/blood.V116.21.68.68
Published: 2010
Journal Articles

Reduction in Immunoglobulin (IVIG or Anti D) Use in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving AMG 531: Results from Two Phase 3 Randomized Placebo-Controlled Trials.

Vinod Pullarkat, Terry B. Gernsheimer, J. Th. M. de Wolf, Troy H. Guthrie, Jr., Adrian Newland, Jeffrey S. Wasser, Solomon I. Hamburg, Sue Gao, Ron Stewart, Janet L. Nichol
Journal: Blood
Blood (2007) 110 (11): 1304.
https://doi.org/10.1182/blood.V110.11.1304.1304
Published: 2007
Journal Articles

Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura.

James B. Bussel, David J. Kuter, James N. George, Louis M. Aledort, Alan E. Lichtin, Roger M. Lyons, Jorge Nieva, Jeffrey S. Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois LeFrere, Martin R. Schipperus, Reggie Kelly, Jenny Christal, Chien-Feng Chen, Janet L. Nichol
Journal: Blood
Blood (2005) 106 (11): 220.
https://doi.org/10.1182/blood.V106.11.220.220
Published: 2005